I now have comprehensive content for a complete MS findings overview. Let me compile everything:
Multiple Sclerosis (MS) — All Findings
Overview
MS is a chronic immune-mediated demyelinating disease of the CNS. It occurs 2–2.5× more often in women, typically manifests in the 3rd–4th decade, and has a prevalence of ~309/100,000 in the US (~730,000 Americans; ~2.8 million worldwide).
Clinical Findings
Presenting Symptoms
| System | Symptoms |
|---|
| Visual | Optic neuritis — monocular blurring, pain on eye movement, central scotoma (centrocecal), red color desaturation |
| Sensory | Paresthesias (circumferential, non-dermatomal), bandlike pain around trunk or limb, Lhermitte sign |
| Motor | Limb weakness, spasticity, hyperreflexia |
| Cerebellar | Imbalance, incoordination, intention tremor, scanning speech |
| Bladder | Urgency, frequency, incomplete emptying |
| Fatigue | Most common symptom overall |
| Cognitive/Psych | Depression (37–54%), cognitive slowing, euphoria |
Key Signs on Examination
- Lhermitte sign — electrical sensation down the spine into limbs on neck flexion; indicates cervical cord demyelination
- Optic neuritis — afferent pupillary defect (Marcus Gunn), swollen or normal-appearing disc; visual recovery common but often incomplete
- Internuclear ophthalmoplegia (INO) — impaired adduction of one eye with nystagmus in the abducting eye; due to MLF demyelination — highly suggestive of MS in a young patient
- Sensory levels — incomplete, often asymmetric, may differ by modality (dorsal columns vs. spinothalamic)
- Upper motor neuron signs — hyperreflexia, extensor plantar response (Babinski sign), clonus
- Charcot triad — intention tremor, scanning speech, nystagmus (classic but rare)
- Uhthoff phenomenon — worsening of symptoms with increased body temperature (hot weather, exercise, fever)
MRI Findings (Most Sensitive Investigation — >95% Abnormal in Definite MS)
Axial FLAIR/T2 sequences showing classic periventricular MS plaques, including "Dawson's fingers" oriented perpendicular to the ventricles
T2-FLAIR showing periventricular plaques (A), gadolinium ring-enhancing active lesions (B–C), and T1 "black holes" representing axonal loss (D–E)
T2 / FLAIR — White Lesions (Most Sensitive)
- Size: 2 mm – 2 cm (occasionally tumor-like)
- Shape: Ovoid, elliptical, discrete borders, no mass effect
- Classic locations (McDonald 2017 criteria — lesions in ≥2 of 4 areas):
- Periventricular — perpendicular to ventricle walls = "Dawson's fingers" (most characteristic)
- Juxtacortical/cortical
- Infratentorial — cerebellar peduncles, brainstem
- Spinal cord — dorsolateral cervical cord
T1 Post-Gadolinium — Active Inflammation
- Gadolinium enhancement = blood-brain barrier breakdown = active/new lesion
- Pattern: homogeneous, central, or ring-enhancing
- Typically persists 2–8 weeks
- Provides evidence for dissemination in time (DIT) when concurrent non-enhancing T2 lesions are present
T1 Pre-Contrast — Chronic Damage
- "Black holes" = persistent T1 hypointensities = axonal loss and atrophy (irreversible damage)
Spinal Cord MRI
- Dorsolateral plaques on sagittal T2; typically <2 vertebral segments (vs. NMO which spans ≥3 segments)
CSF Findings
| Test | Finding |
|---|
| Cell count | Mild lymphocytic pleocytosis (usually <50 WBCs/µL); >50 cells or neutrophils is atypical |
| Total protein | Mildly elevated or normal; >100 mg/dL is unusual for MS |
| Glucose | Normal |
| Oligoclonal IgG bands (OCBs) | Present in 85–90% of clinically definite MS (absent in serum = intrathecal production) |
| IgG index | Elevated (>0.7) — indicates intrathecal immunoglobulin synthesis |
| Myelin basic protein | May be elevated but non-specific (elevated in any CNS tissue destruction) |
CSF is not mandatory when clinical + MRI evidence is sufficient; it is recommended when the diagnosis is uncertain or infection/malignancy must be excluded.
Evoked Potentials
| Type | Finding |
|---|
| Visual evoked potentials (VEP) | Prolonged P100 latency — most clinically useful; documents subclinical optic nerve lesion |
| Brainstem auditory evoked potentials (BAEP) | Delay of central conduction; wave I may be abnormal |
| Somatosensory evoked potentials (SSEP) | Prolonged central conduction time |
Evoked potentials can reveal clinically silent lesions, aiding in demonstrating dissemination in space.
2017 McDonald Diagnostic Criteria (Summary)
The diagnosis requires evidence of dissemination in space (DIS) and dissemination in time (DIT):
DIS on MRI = ≥1 T2 lesion in ≥2 of 4 regions:
- Periventricular, juxtacortical/cortical, infratentorial, spinal cord
DIT on MRI = simultaneous presence of:
- Asymptomatic gadolinium-enhancing AND non-enhancing T2 lesions, OR
- A new T2/enhancing lesion on follow-up scan
CSF shortcut: Positive CSF-specific oligoclonal bands can substitute for DIT in a clinically isolated syndrome (CIS).
Pathological Findings (Gross & Microscopic)
| Finding | Description |
|---|
| Plaques | Sharply demarcated areas of demyelination in white matter ± gray matter |
| Active plaques | Perivascular lymphocytic infiltrates (CD4+/CD8+ T cells, macrophages), myelin stripping |
| Chronic plaques | Hypocellular, gliotic, axonal loss, "shadow plaques" at edges (remyelination) |
| Axonal transection | Occurs even in acute lesions; underlies irreversible disability |
| Cortical demyelination | Common but underdetected by conventional MRI; correlates with cognitive impairment |
Disease Course Subtypes
| Type | Features |
|---|
| RRMS (85–90% at onset) | Distinct relapses with full or partial recovery; most common |
| SPMS | Progressive accumulation of disability after initial RR phase |
| PPMS (~10–15%) | Progressive from onset, no relapses; more spinal cord-dominant |
| CIS | First demyelinating event; converts to MS if McDonald criteria are later fulfilled |
Disability Measurement
Expanded Disability Status Scale (EDSS) (Kurtzke scale) — assesses 7 functional systems:
- Pyramidal, cerebellar, brainstem, sensory, bowel/bladder, visual, cerebral
Sources: Goldman-Cecil Medicine 26e, Ch. 380; Harrison's Principles of Internal Medicine 22e, Ch. 50; Bradley and Daroff's Neurology in Clinical Practice